← Journal
July 2026

Why FemTech Keeps Solving the Wrong Problem

There are now hundreds of apps that will tell a woman when she's ovulating. What almost none of them will tell her is why that matters, what her fertile window actually means for her body, or how her fertility potential changes over time. We've built extraordinary tools for tracking — and left a much bigger gap in understanding.

This isn't a minor oversight. It's the difference between data and knowledge.

Tracking is not the same as awareness

Fertility awareness isn't just knowing your cycle day. It's understanding reproductive ageing, recognising the factors that influence fertility, and having realistic expectations about family planning — timely enough to act on that knowledge, not after the window has already narrowed.

In our recent systematic review, presented at ESHRE's 42nd Annual Meeting in London, we looked at fertility awareness across South Asian countries — nearly 40 studies, over 26,000 participants, spanning almost two decades of research. The pattern was strikingly consistent: awareness of reproductive ageing and the fertile window remained poor across nearly every population group we studied, regardless of education level or access to information. Fertility myths persisted even where healthcare access had genuinely improved.

Where the gap actually sits

A few things stood out:

What this means for FemTech

Most fertility technology today is optimised for tracking behaviour that's already happening — a cycle already in progress, a pregnancy already being planned. Far fewer products are built to reach people before those decisions are close at hand, when education could actually reshape the timeline of a family-building decision.

If we want FemTech to genuinely close the reproductive health gap — rather than just digitising it — the next wave of tools needs to move upstream: delivering fertility education before major decisions are made, standardising evidence-based information across healthcare settings, and designing programmes that address stigma and misconception directly, not just data collection.

That's the space I spend most of my time in now — the intersection of clinical evidence and the products trying to translate it into something people can actually act on. It's why I do the research, and it's why I advise the companies I do.

More on this soon.


Dr. Ashlesha Patwardhan is a Medical Doctor and Reproductive Health Consultant advising FemTech companies and healthcare organisations on women's health innovation.